NCT00310232 2024-04-02
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Terminated
Ontario Clinical Oncology Group (OCOG)
Wake Forest University Health Sciences
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.